Investment ThemesDetailed Quotes
Cancer Research
Watchlist
Cancer Research includes companies working on scientific research aimed at understanding the causes, prevention, diagnosis, treatment, and potential cures for cancer. It includes many disciplines, from biology and genetics, to clinical trials and drug development, with the ultimate goal of improving cancer care and outcomes. Cancer research companies are developing life-saving treatments and diagnostics for a growing market in high demand. These companies constantly innovate, have a global reach, and form important strategic partnerships, which makes them appealing to investors looking for profits and supporting health progress.
- 1115.235
- +14.479+1.32%
Close Nov 21 16:00 ET
1117.131High1098.141Low
1100.808Open1100.756Pre Close79.37MVolume9Rise28.60P/E (Static)4.13BTurnover--Flatline0.57%Turnover Ratio871.79BMarket Cap--Fall861.10BFloat Cap
Constituent Stocks: 9Top Rising: ARAY+3.28%
Market up this is red , Market down this is red..lol
Gapping up
$Deere (DE.US)$ 's stock rose by 1.6% following their announcement of fourth-quarter earnings that surpassed analyst forecasts, despite substantial market hurdles.
Cryptocurrency-related stocks experienced a widespread surge. $MicroStrategy (MSTR.US)$ saw a significant increase, jumping over 13%, while $MARA Holdings (MARA.US)$ climbed more than 11%.
$Snowflake (SNOW.US)$ 's shares surged 23.3% as ...
1. most pharma stocks are facing lots of uncertainties with Trump’s new administration including MRK, MRNA, NOVO etc etc
2. technically it has broken all support lines except MA250 (monthy) and net fund is flowing out.
Wil monitor if can hold the last bastion in the next couple weeks else …
No comment yet